Skip to main content
. 2016 Nov 3;26:16081. doi: 10.1038/npjpcrm.2016.81

Table 4. How patients usually refer to inhalers when talking with a healthcare professional.

Patient group Usually, n (%) Often, n (%) Sometimes, n (%) Never, n (%) Total, n P value
By colour (e.g., ‘I use my blue inhaler if my symptoms get worse’)
 Asthma (n=1,755) 813 (50.7%) 286 (17.8%) 332 (20.7%) 172 (10.7%) 1,603 0.86
 COPD (n=212) 79 (48.2%) 32 (19.5%) 33 (20.1%) 20 (12.2%) 164  
 All (n=2,127) 943 (49.8%) 309 (17.9%) 397 (21.0%) 214 (11.3%) 1893  
             
By the brand name (e.g., Ventolin, Flixotide, Symbicort)
 Asthma (n=1,755) 513 (35.1%) 313 (19.6%) 458 (28.7%) 313 (19.6%) 1,597 <0.005
 COPD (n=212) 80 (48.8%) 24 (14.6%) 40 (24.4%) 20 (12.2%) 164  
 All (n=2,127) 673 (35.4%) 360 (18.9%) 523 (27.5%) 346 (18.2%) 1902  
             
By the medicine inside (generic name) (e.g., salbutamol, salmeterol, budesonide)
 Asthma (n=1,755) 250 (16.7%) 205 (13.7%) 591 (39.4%) 454 (30.3%) 1,500 <0.005
 COPD (n=212) 45 (34.1%) 17 (12.9%) 45 (34.1) 25 (18.9%) 132  
 All (n=2,127) 328 (18.7%) 247 (14.1%) 679 (38.7%) 502 (28.6%) 1757